view article
Figure 3
SAR by catalog: the structure of resorcinol fragment 1 bound to the active site of Hsp90 was used to select compound 2, which formed the initial lead series that generated a pre-clinical candidate.

Journal logoJOURNAL OF
SYNCHROTRON
RADIATION
ISSN: 1600-5775
Volume 15| Part 3| May 2008| Pages 227-230
https://doi.org/10.1107/S090904950705666X
Follow J. Synchrotron Rad.
Sign up for e-alerts
E-alerts
Follow J. Synchrotron Rad. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS